Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma

NCT04410523 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

335

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor Desicion

Conditions

Asthma

Interventions

DRUG: CSJ117
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals